NCT05626114: A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (GAlette); Adaptive Optics (AO) Retinal Imaging Substudy in Association With Study GR44251
- State
- Under way
- Phase
- Phase 2
- People
- 60 planned
- Started
- 23 Mar 2023
- Primary completion
- 1 Mar 2031
- Arms
- OpRegen
- Results
- None posted
- 23 Nov 2022: Trial registered
- 23 Mar 2023: Trial started